Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
50.33
-0.53 (-1.04%)
At close: Nov 6, 2026, 4:00 PM EST
50.40
+0.07 (0.14%)
After-hours: Nov 6, 2026, 7:30 PM EST
Qiagen Employees
Qiagen had 5,400 employees as of September 30, 2026. The number of employees decreased by 300 or 5.26% compared to the same quarter last year. That makes Qiagen the 5,367th largest employer in the world and 1,107th in the United States.
Employees
5,400
Change (1Y)
-300
Growth (1Y)
-5.26%
Revenue / Employee
$391,787
Profits / Employee
$71,284
Market Cap
10.39B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 5,400 | -300 | -5.26% |
| Dec 31, 2025 | 5,700 | 0 | - |
| Dec 31, 2024 | 5,700 | -267 | -4.47% |
| Dec 31, 2023 | 5,967 | -211 | -3.42% |
| Dec 31, 2022 | 6,178 | 150 | 2.49% |
| Dec 31, 2021 | 6,028 | 418 | 7.45% |
| Dec 31, 2020 | 5,610 | 514 | 10.09% |
| Dec 31, 2019 | 5,096 | 144 | 2.91% |
| Dec 31, 2018 | 4,952 | 264 | 5.63% |
| Dec 31, 2017 | 4,688 | 4 | 0.09% |
| Dec 31, 2016 | 4,684 | 125 | 2.74% |
| Dec 31, 2015 | 4,559 | 220 | 5.07% |
| Dec 31, 2014 | 4,339 | 324 | 8.07% |
| Dec 31, 2013 | 4,015 | 16 | 0.40% |
| Dec 31, 2012 | 3,999 | 61 | 1.55% |
| Dec 31, 2011 | 3,938 | 351 | 9.79% |
| Dec 31, 2010 | 3,587 | 92 | 2.63% |
| Dec 31, 2009 | 3,495 | 454 | 14.93% |
| Dec 31, 2008 | 3,041 | 379 | 14.24% |
| Dec 31, 2007 | 2,662 | 708 | 36.23% |
| Dec 31, 2006 | 1,954 | 365 | 22.97% |
| Dec 31, 2005 | 1,589 | 267 | 20.20% |
| Dec 31, 2004 | 1,322 | -231 | -14.87% |
| Dec 31, 2003 | 1,553 | -98 | -5.94% |
| Dec 31, 2002 | 1,651 | 94 | 6.04% |
| Dec 31, 2001 | 1,557 | 242 | 18.40% |
| Dec 31, 2000 | 1,315 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ICON Public Limited Company | 40,200 |
| Charles River Laboratories International | 19,700 |
| Revvity | 11,000 |
| RadNet | 9,276 |
| Medpace Holdings | 6,600 |
| Sotera Health Company | 3,000 |
| Guardant Health | 2,506 |
| GRAIL | 910 |
QGEN News
- 1 day ago - Qiagen shareholders approve Jonathan Pratt as managing director - TheFly
- 1 day ago - QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director - Business Wire
- 1 day ago - Qiagen Transcript: EGM 2026 - Transcripts
- 3 days ago - Qiagen reports Q3 EPS 65c, consensus 63c - TheFly
- 3 days ago - QIAGEN Reports Full Q3 2026 Results - Business Wire
- 3 days ago - Qiagen Earnings release: Q3 2026 - Filings
- 10 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ultralife Corporation (Nasdaq – ULBI), QIAGEN N.V. (NYSE – QGEN), CCC Intelligent Solutions Holdings Inc. (Nasdaq – CCC), Penske Automotive Group, Inc. (NYSE – PAG) - GlobeNewsWire
- 11 days ago - Qiagen downgraded to Equal Weight from Overweight at Barclays - TheFly